Mevalonate pathway-triggered phase transition of injectable hydrogel for cholesterol-downregulated therapy of osteoarthritis
Dysregulation of mevalonate pathway, an essential metabolic route involving coenzyme A (CoASH) and cholesterol, contributes significantly to escalating cartilage degradation. Existing treatments rely on the simvastatin delivery via tunable sol-gel transition mechanisms of injectable hydrogel. Howeve...
Saved in:
Main Authors: | Akhmad Irhas Robby, Ee Hyun Kim, Kang Moo Huh, Eun-Jung Jin, Ki Dong Park, Sung Young Park |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2025-09-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X2500283X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mevalonate kinase deficiency syndrome: Single center experience
by: A. L. Kozlova, et al.
Published: (2021-07-01) -
PERIODIC FEVER SYNDROME (MEVALONATE KINASE DEFICIENCY, HYPERIMMUNOGLOBULINEMIA D SYNDROME) IN CHILDREN
by: Yu. S. Patrusheva, et al.
Published: (2012-03-01) -
The Cellular and Mitochondrial Consequences of Mevalonate Pathway Inhibition by Nitrogen-Containing Bisphosphonates: A Narrative Review
by: Adrianna Budzinska, et al.
Published: (2025-07-01) -
EFFECTS OF MEVALONATE PATHWAY MODULATORS UPON REACTIVITY OF MACROPHAGES IN E XPERIMENTAL NEPHROSCLEROSIS
by: Ya. Sh. Schwarz, et al.
Published: (2014-07-01) -
Improving Cofactor Promiscuity of HMG-CoA Reductase from <i>Ruegeria pomeroyi</i> Through Rational Design
by: Haizhao Xue, et al.
Published: (2025-07-01)